Control of hepatitis B in the United Kingdom

Vaccine

Volumn 16, Issue SUPPL., 1998, Pages

  Ramsay, Mary ^a   Gay, Nigel ^a   Balogun, Koye ^a   Collins, Marian ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Economic evaluation; Hepatitis B; Surveillance; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

CHILD; CONFERENCE PAPER; COST BENEFIT ANALYSIS; FEMALE; HEALTH PROGRAM; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRENATAL SCREENING; PRIORITY JOURNAL; UNITED KINGDOM; VACCINATION; VIRUS TRANSMISSION;

ACUTE DISEASE; ADULT; CHILD; GREAT BRITAIN; HEPATITIS B; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; NATIONAL HEALTH PROGRAMS; RISK FACTORS;

EID: 0032429950     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00295-3     Document Type: Conference Paper

References (14)

1. UK Health Departments. Immunisation against infectious disease, 1996. London: HMSO, 1996.
2. Brook M, Lever A, Kelly D et al. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Quart. J. Med. 1989;71:313-7.
3. Grosheide P, Van Damme P. Prevention and control of hepatitis B in the community. In: Hallauer J, Kane MA, McCloy E, Meheus A, Roure C, editors. Communicable Diseases Series no. 1. Viral Hepatitis Prevention Board. Antwerp: University of Antwerp, 1996.
4. Polakoff S, Tillett H. Routine laboratory reports of patients with acute hepatitis B as indicators of incidence of the disease. J. Infect. 1984;8:44-8.
5. Anon. Surveillance of viral infections in donated blood: England and Wales, 1996. Commun. Disease Report 1997;29:258.
6. Boxall E, Skidmore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol. Infect. 1994;113:523-8.
7. Unlinked Anonymous Surveys Steering Group. Unlinked anonymous HIV prevalence monitoring programme England and Wales. London: Department of Health, 1997.
8. Hart GJ, Dawson J, Fitzpatrick RM et al. Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men. AIDS 1993;7:863-9.
9. Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol. Infect. 1998 (in press).
10. Hesketh LM, Rowlatt JD, Gay NJ, Morgan-Capner P, Miller E. Childhood infection with hepatitis A and B viruses in England and Wales. Commun. Disease Report 1997;4:R60-R63.
11. Dwyer MJ, McIntyre PG. Antenatal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area. Epidemiol. Infect. 1996;117:121-31.
12. Mangtani P, Hall AJ, Normand CEM. Hepatitis B vaccination: the cost of alternative strategies in England and Wales. J. Epidemiol. Commun. Health 1995;49:238-44.
13. Fenn P, Gray A, McGuire A. An economic evaluation of universal vaccination against hepatitis B virus. J. Infect. 1996;32:197-204.
14. Williams J, Nokes D, Anderson R. Targeted hepatitis B vaccination - a cost effective immunisation strategy for the UK. J. Epidemiol. Commun. Health 1996;50:667-73.